A novel genetic assay for risk assessment of cognitive decline in Alzheimer’s Disease

Project description

Earlier diagnosis of Alzheimer's by a new genetic assay

Fields of science

• natural sciences › computer and information sciences › software
• natural sciences › biological sciences › genetics › nucleotides
• humanities › arts › architectural design
• medical and health sciences › basic medicine › neurology › dementia › alzheimer
• engineering and technology › medical engineering › diagnostic imaging › magnetic resonance imaging

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Funding Scheme

SME-1 - SME instrument phase 1

Coordinator

CYTOX LIMITED

Address

53 Fountain Street
M2 2AN Manchester
United Kingdom

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 50 000